[{"NetIncomeLoss_3_Q3_USD":3932000.0,"PurchaseObligation_0_Q3_USD":32944000.0,"Depreciation_3_Q3_USD":656000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-18077000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1_Q3_pure":0.0041,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_3_Q3_pure":0.0165,"DerivativeAssets_0_Q3_USD":2549000.0,"PurchaseObligationDueInFifthYear_0_Q3_USD":0.0,"InventoryFinishedGoods_0_Q3_USD":51000.0,"RoyaltyExpense_1_Q3_USD":3260000.0,"RoyaltyExpense_3_Q3_USD":9120000.0,"InterestPaidNet_3_Q3_USD":1878000.0,"OperatingLeaseRightOfUseAssetAmortizationExpense_1_Q3_USD":509000.0,"OperatingLeaseRightOfUseAssetAmortizationExpense_3_Q3_USD":980000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q3_USD":0.0,"AccruedLiabilitiesCurrent_0_Q3_USD":24445000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"RepaymentsOfLongTermDebt_3_Q3_USD":3000000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q3_USD":1369000.0,"AccruedRoyaltiesCurrent_0_Q3_USD":6906000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour_0_Q3_USD":0.0,"PaymentsToAcquireInvestments_3_Q3_USD":17500000.0,"OperatingLeaseLiability_0_Q3_USD":3962000.0,"LiabilitiesFairValueDisclosure_0_Q3_USD":0.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_3_Q3_USD":1310000.0,"IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet_3_Q3_USD":1845000.0,"AccruedSalariesCurrent_0_Q3_USD":4742000.0,"ReceivablesLongTermContractsOrPrograms_0_Q3_USD":5000000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_3_Q3_USD":555000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":42000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":3362057.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":3130198.0,"TreasuryStockShares_0_Q3_shares":3594551.0,"CostOfGoodsAndServicesSold_1_Q3_USD":8726000.0,"CostOfGoodsAndServicesSold_3_Q3_USD":23804000.0,"ProceedsFromIssuanceOfLongTermDebt_3_Q3_USD":110000000.0,"SellingGeneralAndAdministrativeExpense_1_Q3_USD":17697000.0,"SellingGeneralAndAdministrativeExpense_3_Q3_USD":60411000.0,"LongTermDebtCurrent_0_Q3_USD":8000000.0,"LongTermDebt_0_Q3_USD":36000000.0,"OperatingLeaseExpense_1_Q3_USD":276000.0,"OperatingLeaseExpense_3_Q3_USD":910000.0,"AssetsCurrent_0_Q3_USD":163796000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":1291000.0,"GoodwillImpairmentLoss_3_Q3_USD":0.0,"GoodwillImpairmentLoss_1_Q3_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":662700.0,"TreasuryStockValue_0_Q3_USD":199860000.0,"PrepaidTaxes_0_Q3_USD":315000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":2844000.0,"PurchaseObligationDueInNextTwelveMonths_0_Q3_USD":0.0,"IncomeTaxExpenseBenefit_3_Q3_USD":7358000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":1866000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q3_pure":0.5542,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_3_Q3_pure":0.5498,"AccountsReceivableNetCurrent_0_Q3_USD":52199000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-6049000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-10249000.0,"AssetsFairValueDisclosure_0_Q3_USD":98692000.0,"PurchaseObligationDueInSecondYear_0_Q3_USD":0.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":13786803.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":13917800.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q3_USD":2622000.0,"EarningsPerShareBasic_3_Q3_USD":0.29,"EarningsPerShareBasic_1_Q3_USD":0.52,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q3_USD":9516000.0,"InventoryRawMaterials_0_Q3_USD":2439000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":5903000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":4828000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":21390000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":641000.0,"CommonStockValue_0_Q3_USD":17000.0,"Liabilities_0_Q3_USD":75374000.0,"FairValueLiabilitiesMeasuredOnRecurringBasisObligations_0_Q3_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q3_USD":413000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":89681000.0,"OtherAssetsNoncurrent_0_Q3_USD":13575000.0,"AmortizationOfIntangibleAssets_1_Q3_USD":667000.0,"AmortizationOfIntangibleAssets_3_Q3_USD":1999000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":7606000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":7059000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":3932000.0,"MarketingAndAdvertisingExpense_1_Q3_USD":316000.0,"MarketingAndAdvertisingExpense_3_Q3_USD":2204000.0,"IncreaseDecreaseInInventories_3_Q3_USD":20000.0,"OtherAssetsCurrent_0_Q3_USD":3671000.0,"CostsAndExpenses_1_Q3_USD":34511000.0,"CostsAndExpenses_3_Q3_USD":114725000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":-31754000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q3_pure":0.21,"EffectiveIncomeTaxRateContinuingOperations_3_Q3_pure":0.65,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares_3_Q3_shares":185615.0,"DepreciationDepletionAndAmortization_1_Q3_USD":196000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":656000.0,"TreasuryStockValueAcquiredCostMethod_3_Q3_USD":27999000.0,"TreasuryStockValueAcquiredCostMethod_1_Q3_USD":23000000.0,"RepaymentsOfLinesOfCredit_3_Q3_USD":110000000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":1376000.0,"PurchaseObligationDueInFourthYear_0_Q3_USD":0.0,"IncomeTaxesPaidNet_3_Q3_USD":3036000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":15330000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":89681000.0,"InterestExpense_1_Q3_USD":489000.0,"InterestExpense_3_Q3_USD":2164000.0,"NonoperatingIncomeExpense_1_Q3_USD":-6492000.0,"NonoperatingIncomeExpense_3_Q3_USD":-11871000.0,"AccountsPayableCurrent_0_Q3_USD":13068000.0,"LiabilitiesCurrent_0_Q3_USD":45513000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":1362000.0,"InventoryWorkInProcess_0_Q3_USD":4096000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":13531372.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":13620981.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":29737000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":4722000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3_Q3_USD":18435000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3_Q3_USD":1310000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":8925000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":11290000.0,"Goodwill_0_Q3_USD":39743000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_0_Q3_USD":2000000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":4975000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":555000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q3_USD":1570000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q3_USD":86343000.0,"LongTermDebtNoncurrent_0_Q3_USD":27017000.0,"NetIncomeLoss_1_Q3_USD":7059000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":2123000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PrepaidInsurance_0_Q3_USD":440000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q3_USD":26000000.0,"OperatingLeasePayments_3_Q3_USD":980000.0,"FiniteLivedIntangibleAssetsNet_0_Q3_USD":13584000.0,"OtherAssetsFairValueDisclosure_0_Q3_USD":9800000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":41951.0,"PurchaseObligationDueAfterFifthYear_0_Q3_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1_Q3_pure":0.0037,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_3_Q3_pure":0.0037,"IncrementalCommonSharesAttributableToCallOptionsAndWarrants_1_Q3_shares":255431.0,"IncrementalCommonSharesAttributableToCallOptionsAndWarrants_3_Q3_shares":296819.0,"AdditionalPaidInCapital_0_Q3_USD":296198000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q3_shares":13786803.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_3_Q3_shares":13917800.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.06,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive_0_Q3_USD":0.0,"IntangibleAssetsNetExcludingGoodwill_0_Q3_USD":13584000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":1320000.0,"DeferredIncomeTaxesAndTaxCredits_3_Q3_USD":-1671000.0,"AmortizationOfFinancingCosts_3_Q3_USD":301000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q3_USD":1898000.0,"EarningsPerShareDiluted_1_Q3_USD":0.51,"InvestmentIncomeInterest_1_Q3_USD":46000.0,"InvestmentIncomeInterest_3_Q3_USD":542000.0,"InventoryNet_0_Q3_USD":6586000.0,"PaymentsForRepurchaseOfCommonStock_3_Q3_USD":27999000.0,"OperatingIncomeLoss_1_Q3_USD":15417000.0,"OperatingIncomeLoss_3_Q3_USD":23161000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":49928000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":137886000.0,"CommonStockSharesAuthorized_0_Q3_shares":50000000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":820000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":1941000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"DeferredIncomeTaxAssetsNet_0_Q3_USD":15340000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_0_Q3_USD":8000000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":3578000.0,"ShareBasedCompensation_3_Q3_USD":18435000.0,"UnrealizedGainLossOnInvestments_3_Q3_USD":-7700000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive_0_Q3_USD":0.0,"Assets_0_Q3_USD":248161000.0,"CommonStockSharesIssued_0_Q3_shares":16624681.0,"UnrecognizedTaxBenefits_0_Q3_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_3_Q3_pure":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q3_pure":0.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":7122000.0,"FiniteLivedIntangibleAssetsGross_0_Q3_USD":23100000.0,"EarningsPerShareDiluted_3_Q3_USD":0.28,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":4195000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-20094000.0,"DeferredFinanceCostsNoncurrentGross_0_Q3_USD":1000000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":76432000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":3531295.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":577000.0,"PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear_0_Q3_USD":32944000.0,"StockholdersEquity_0_Q3_USD":172787000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":2844000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":2114000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":842000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q3_USD":665000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":1118000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":7098000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":4722000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":18435000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0_Q3_USD":0.0,"PreferredStockSharesAuthorized_0_Q3_shares":1500000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":248161000.0,"OperatingLeaseCost_3_Q3_USD":980000.0,"PreferredStockValue_0_Q3_USD":0.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3_Q3_USD":-3916000.0,"PurchaseObligationDueInThirdYear_0_Q3_USD":0.0,"Ticker":"EGRX","CIK":"827871","name":"EAGLE PHARMACEUTICALS, INC.","OfficialName":"Eagle Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"3","uom":"USD","footnote":"nan","Market Cap":"635235963.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201102"}]